Despite the limitations above, we still could conclude that beside clinical factors, like stem cell transplantation, CR at transplantation and chemotherapy refractory, MLL rearrangement and DNA methylating related gene’s mutations, like DNMT3A mutation and TET2 mutation, were the equally critical features to predict long-term survival for AML. This evidence concerns the gene KMT2A and acute myeloid leukemia.